Sivik Global Healthcare LLC Sage Therapeutics, Inc. Transaction History

Sivik Global Healthcare LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$26.15 - $77.24 $392,250 - $1.16 Million	-15,000 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$60.18 - $154.77 $300,900 - $773,850	5,000 Added 50.0%	15,000 $1.08 Million
Q3 2019 Nov 12, 2019	SELL	$140.29 - $189.96 $1.05 Million - $1.42 Million	-7,500 Reduced 42.86%	10,000 $1.4 Million
Q2 2019 Aug 14, 2019	BUY	$157.85 - $183.09 $1.18 Million - $1.37 Million	7,500 Added 75.0%	17,500 $3.2 Million
Q3 2018 Nov 13, 2018	SELL	$138.11 - $169.04 $2.07 Million - $2.54 Million	-15,000 Reduced 60.0%	10,000 $1.41 Million
Q2 2018 Aug 06, 2018	BUY	$140.36 - $175.76 $1.4 Million - $1.76 Million	10,000 Added 66.67%	25,000 $3.91 Million
Q1 2018 May 08, 2018	SELL	$152.15 - $192.33 $760,750 - $961,650	-5,000 Reduced 25.0%	15,000 $2.42 Million
Q4 2017 Feb 08, 2018	BUY	$60.72 - $167.34 $1.21 Million - $3.35 Million	20,000	20,000 $3.29 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $340M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

Stay updated on Sivik Global Healthcare LLC with notifications on news.